<div id="readability-page-1"><p>Blend Labs, Inc. (NYSE:BLND - Get Free Report)'s share price was up 6.3% on Monday . The company traded as high as $3.33 and last traded at $3.3060. Approximately 1,296,376 shares traded hands during trading, a decline of 58% from the average daily volume of 3,114,604 shares. The stock had previously closed at $3.11.</p><h2>Analyst Upgrades and Downgrades</h2><p>A number of brokerages have recently issued reports on BLND. Wall Street Zen upgraded Blend Labs from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Sunday, November 16th. Weiss Ratings  reaffirmed a &#34;sell (d-)&#34; rating on shares of Blend Labs in a research report on Wednesday, October 8th. Canaccord Genuity Group  reiterated a &#34;buy&#34; rating and issued a $5.25 target price on shares of Blend Labs in a report on Tuesday, October 28th. Finally, UBS Group lowered their price target on shares of Blend Labs from $3.50 to $3.00 and set a &#34;neutral&#34; rating on the stock in a report on Monday, November 10th. One research analyst  has rated the stock with a Strong Buy rating, four have assigned  a Buy rating, two have assigned  a Hold rating and one  has issued  a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $4.80.</p><p><b>View Our Latest Analysis on BLND</b></p><h2>Blend Labs Price Performance</h2><p>The business's fifty day moving average price is $3.24 and its two-hundred day moving average price is $3.44. The stock has a market capitalization of $837.69 million, a PE ratio of -32.25 and a beta of 1.23. </p><h2>Insider Buying and Selling</h2><p>In other news, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of $3.34, for a total value of $83,500.00. Following the sale, the insider owned 687,909 shares in the company, valued at $2,297,616.06. This represents a 3.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. Insiders own  35.52% of the company's stock. </p><h2>Institutional Inflows and Outflows</h2><p>Several institutional investors have recently modified their holdings of BLND. Park West Asset Management LLC purchased a new stake in shares of  Blend Labs during the 3rd quarter valued at approximately $6,205,000.  Marshall Wace LLP raised its position in  Blend Labs by 157.6% in the second quarter. Marshall Wace LLP now owns 2,522,141 shares of the company's stock valued at $8,323,000 after purchasing an additional 1,543,220 shares during the period.  Prospect Capital Advisors LLC lifted its stake in shares of  Blend Labs by 338.2% in the 3rd quarter. Prospect Capital Advisors LLC now owns 1,820,150 shares of the company's stock valued at $6,644,000 after purchasing an additional 1,404,750 shares during the last quarter.  Summit Partners Public Asset Management LLC acquired a new position in shares of  Blend Labs in the 3rd quarter valued at $4,490,000.  Finally, Mirabella Financial Services LLP grew its holdings in shares of  Blend Labs by 64.5% during the 3rd quarter. Mirabella Financial Services LLP now owns 2,643,777 shares of the company's stock worth $9,650,000 after purchasing an additional 1,036,777 shares during the period. Hedge funds and other institutional investors own  52.56% of the company's stock. </p><h2>Blend Labs Company Profile</h2> (Get Free Report)<p>Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Blend Labs</li><li>Consumer Staples Stocks, Explained</li><li>5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up)</li><li>How to trade using analyst ratings</li><li>Why FuelCell Energy Stock Is Soaring After a Government Deal</li><li>Stock Market Upgrades: What Are They?</li><li>SoftBank’s Next AI Move? DigitalBridge Rockets 46% on Takeover Buzz</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Blend Labs Right Now?</h2><p>Before you consider Blend Labs, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.</p><p>While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

BLND

<p>Blend Labs (NYSE:BLND) shares rose 6.3% to $3.3060, with a decline in trading volume. Analysts have mixed ratings: Wall Street Zen upgraded to 'hold', Weiss Ratings reaffirmed 'sell', Canaccord Genuity Group reiterated 'buy' with a $5.25 target, and UBS Group set a 'neutral' rating with a $3.00 target. Insider Brian Kneafsey sold shares, reducing his ownership. Institutional investors have modified holdings, with hedge funds owning 52.56%. Blend Labs offers cloud-based software for financial services.</p>

Blend Labs (NYSE:BLND) Trading 6.3% Higher - Still a Buy?